Clinical Data
Real-time intraoperative margin assessment
New clinical research shows MarginProbe reduces re-excision rates for breast conserving surgery by 61%
A study recently presented during the 2017 American Society of Breast Surgeons annual meeting demonstrates that proper use of Dune…
Mapping breast tissue types by miniature radio-frequency near-field spectroscopy sensor in ex-vivo freshly excised specimens
Zvi Kaufman,1,7 Haim Paran,1 Ilana Haas,1 Patricia Malinger,1 Tania Zehavi,2 Tamar Karni,3 Izhak Pappo,3 Judith Sandbank,4 Judith Diment,5 and Tanir…
MarginProbe Reduces the Rate of Re-excision Following Breast Conserving Surgery for Breast Cancer
Jens-Uwe Blohmer1,2 • Julia Tanko2 • Janina Kueper1 • Jessica Groß1,2 • Ragna Volker1,2 • Anna Machleidt1,2 Anna Machleidt: anna.machleidt@charite.de 1 Breast Center,…
Routine Use of the MarginProbe in Partial Mastectomy Patients: Three Centers’ Experience, Including Comparison to Historical Re-Excision Rates
Molly Sebastian, MD, FACS & Stephanie Akbari, MD, FACS; Reinsch Pierce Family Center for Breast Health, Virginia Hospital Center, Arlington,…
The impact use of an intraoperative margin assessment device on re-excision rates
This study was originally published as an Open Access article in Springer Plus and has been recreated under the terms of…
MarginProbe device is able to reduce re-excision rate of breast conserving surgery in invasive and pre-invasive breast cancer independent from any patient or tumor related factors.
San Antonio Breast Cancer Symposium – December 9-13, 2014 Blohmer JU (1,2), Tanko J (2), Groß J (1,2), Völker R…
Combined experience at three breast centers with routine use of an intraoperative margin assessment device including comparison to historical re-excision rates
Molly Sebastian, MD, FACS & Stephanie Akbari, MD, FACS; Reinsch Pierce Family Center for Breast Health, Virginia Hospital Center, Arlington,…
Combined experience at three breast centers with routine use of an intraoperative margin assessment device including comparison to historical re-excision rates.
Molly Sebastian, MD, FACS & Stephanie Akbari, MD, FACS; Reinsch Pierce Family Center for Breast Health, Virginia Hospital Center, Arlington,…
MarginProbe®- final results of the German post-market study in breast conserving surgery of ductal carcinoma in situ.
Thill M1, Dittmer C2, Baumann K3, Friedrichs K4, Blohmer JU5. View the study by clicking here.
A Randomized Prospective Study of Lumpectomy Margin Assessment with Use of MarginProbe in Patients with Nonpalpable Breast Malignancies.
Schnabel, F., Boolbol, S.K., Gittleman, M. et al. Ann Surg Oncol (2014) 21: 1589. doi:10.1245/s10434-014-3602-0 Abstract Background The presence of…
Detection of prostate cancer by radio-frequency near-field spectroscopy in radical prostatectomy ex vivo specimens.
Dotan ZA1, Fridman E, Lindner A, Ramon J, Pode D, Bejar J, Kopolovic J, Pizov G, Sandbank J, Katz R,…
Margins in breast-conserving therapy: have we lost sight of the big picture?
Morrow M. Expert Rev Anticancer Ther. 2008;8(8):1193-1196. View Study
Predictors of re-excision among women undergoing breast-conserving surgery for cancer.
Waljee JF, et al. Ann Surg Oncol. 2008;15(5):1297-1303. View Study
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer
Fisher B, et al. N Engl J Med. 2002;347(16):1233-1241. View Study
Do you want to be up to date?
